For instance, emerging preclinical studies have initiated the exploration of strategies aimed at inhibiting the HA‐degrading function of CEMIP, such as in models of skin ageing,61, 62 while early‐phase investigations in osteoarthritis synovial membranes suggest that reducing CEMIP expression may mitigate inflammation.44 This evidence concerns the gene CEMIP and osteoarthritis.